Ang Ding
Ang Ding has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Hongliang Chen
Obstetrics & Gynecology Hospital of Fudan University, Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases
2 shared publications Hong-Liang Chen
Department of Breast Surgery, Obstetrics and Gynecology Hospital of Fudan University, 419 Fangxie Road, Huangpu District, Shanghai 200011, China
1 shared publication- Kejin Wu
The Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China
1 shared publication - Mao-Li Wang
Breast Surgery Department, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 200011 China
1 shared publication - Maoli Wang
Qufu Normal University
1 shared publication Mingdi Zhang
Department of Breast Surgery, Obstetrics and Gynecology Hospital of Fudan University
1 shared publication
Latest Publications
- 24 April 2019
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 176 (2) , 337-347
Post-mastectomy immediate breast reconstruction is oncologically safe in well-selected T4 locally advanced breast cancer: a large population-based study and matched case–control analysis
Although it is well accepted that the survival outcome is most probably unaffected by immediate breast reconstruction (IBR) for T1–T3 tumors, the safety of IBR in T4 locally advanced breast cancer (LABC) remains unclear.
- 24 April 2019
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 176 (2) , 337-347
Post-mastectomy immediate breast reconstruction is oncologically safe in well-selected T4 locally advanced breast cancer: a large population-based study and matched case–control analysis
Although it is well accepted that the survival outcome is most probably unaffected by immediate breast reconstruction (IBR) for T1–T3 tumors, the safety of IBR in T4 locally advanced breast cancer (LABC) remains unclear.
- Open Access
- 11 May 2016
- Published by Springer Nature in SpringerPlus
- Vol. 5 (1) , 594
Impact of central obesity on prognostic outcome of triple negative breast cancer in Chinese women
To evaluate the prognostic effect of central obesity on triple negative breast cancer (TNBC). 206 TNBC patients treated from June 2006 to June 2015 were enrolled retrospectively. Body mass index (BMI) ≥25 kg/m2 was the standard of obesity and waist circumference ≥80 cm was the standard of central obesity. Patient and tumor characteristics were compared between obesity categories. Survival differences between obesity categories were assessed with log-rank test in the univariate analysis and prognostic factors were then investigated by Cox regression analysis. 81 cases were with obesity (39.3 %). 71 cases were with central obesity (34.5 %). Patients with obesity or central obesity tended to be older (P = 0.022 for obesity; P = 0.013 for central obesity) and to have larger tumor size (P = 0.027 for obesity; P = 0.027 for central obesity). By Cox regression analysis, central obesity (DFS: HR 1.759; 95 % CI 1.009–3.065; P = 0.046. OS: HR 2.297; 95 % CI 1.184–4.456; P = 0.014) was identified as an independent prognostic factor. For central obesity with BMI ≥ 25 kg/m2, the prognostic effect was more apparent (DFS: HR 1.845; 95 % CI 1.059–3.212; P = 0.031. OS: HR 2.377; 95 % CI 1.230–4.593; P = 0.010). Central obesity, especially with high BMI, was an independent prognostic factor for TNBC.
- 11 May 2016
- Published by Springer Nature in SpringerPlus
- Vol. 5 (1) , 594
Open AccessImpact of central obesity on prognostic outcome of triple negative breast cancer in Chinese women
To evaluate the prognostic effect of central obesity on triple negative breast cancer (TNBC). 206 TNBC patients treated from June 2006 to June 2015 were enrolled retrospectively. Body mass index (BMI) ≥25 kg/m2 was the standard of obesity and waist circumference ≥80 cm was the standard of central obesity. Patient and tumor characteristics were compared between obesity categories. Survival differences between obesity categories were assessed with log-rank test in the univariate analysis and prognostic factors were then investigated by Cox regression analysis. 81 cases were with obesity (39.3 %). 71 cases were with central obesity (34.5 %). Patients with obesity or central obesity tended to be older (P = 0.022 for obesity; P = 0.013 for central obesity) and to have larger tumor size (P = 0.027 for obesity; P = 0.027 for central obesity). By Cox regression analysis, central obesity (DFS: HR 1.759; 95 % CI 1.009–3.065; P = 0.046. OS: HR 2.297; 95 % CI 1.184–4.456; P = 0.014) was identified as an independent prognostic factor. For central obesity with BMI ≥ 25 kg/m2, the prognostic effect was more apparent (DFS: HR 1.845; 95 % CI 1.059–3.212; P = 0.031. OS: HR 2.377; 95 % CI 1.230–4.593; P = 0.010). Central obesity, especially with high BMI, was an independent prognostic factor for TNBC.
- 1 December 2015
- Published by Elsevier in The Breast
- Vol. 24 (6) , 723-731
Comparison of invasive micropapillary and triple negative invasive ductal carcinoma of the breast
- 1 December 2015
- Published by Elsevier in The Breast
- Vol. 24 (6) , 723-731
Comparison of invasive micropapillary and triple negative invasive ductal carcinoma of the breast